Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.65
Bid: 5.00
Ask: 6.30
Change: 0.55 (10.78%)
Spread: 1.30 (26.00%)
Open: 5.10
High: 0.00
Low: 0.00
Prev. Close: 5.10
NOG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consent Solicitation

21 Feb 2012 13:33

RNS Number : 8213X
Zhaikmunai LP
21 February 2012
 



Zhaikmunai LLP commences Consent Solicitation in respect of its US$450 million 10.50%

Senior Notes due 2015

 

February 21, 2012. Zhaikmunai L.P. (the "Parent"), a limited partnership established under the laws of Isle of Man announces that Zhaikmunai LLP (the "Issuer"), having its registered office at 59/2 Prospekt Evrazia, Uralsk, West Kazakhstan Oblast, 090002 Kazakhstan has today commenced the solicitation (the "Solicitation") of consents (the "Consents" and each, a "Consent") from Holders of the US$450,000,000 10.50% Senior Notes due 2015 (the "Notes") (ISIN: (RegS)USN97708AA49/(144A)US98951QAA31) (CUSIP:(RegS)N97708AA4/(144A)98951QAA3). The terms and conditions of the Solicitation are described in the Consent Solicitation Statement dated February 21, 2012 (the "Consent Solicitation Statement"). Capitalised terms used in this announcement have the meanings ascribed to them in the Consent Solicitation Statement. The Parent is considering seeking a listing (the "Listing") of all or a portion of its Capital Stock (or all or a portion of the Capital Stock of a new (direct or indirect) holding company of the Issuer ("NewCo")) on either the London Stock Exchange plc (the "London Stock Exchange") or another recognized stock exchange (which may be an unregulated market for purposes of European Union legislation) or alternatively, to list its GDRs on another recognized stock exchange which may, in each case, require the termination of its GDR listing on the London Stock Exchange. In addition, in connection with the Listing and/or in connection with a reorganization of the corporate structure of the Parent and its Restricted Subsidiaries, the Parent and its Restricted Subsidiaries may undertake certain reorganization transactions, which may require the implementation of one or more transactions (the "Reorganization Transactions", as more fully described in the Consent Solicitation Statement). The Issuer, subject to the terms and conditions set forth in the Consent Solicitation Statement, is soliciting the Consents of Holders of Notes to (a) amend and/or waive certain provisions of the Indenture to permit the Parent or Newco to effect the Listing; (b) permit the Parent and/or its Restricted Subsidiaries to undertake certain of the Reorganization Transactions; (c) authorize and direct the Trustee and the Collateral Agent and authorize and direct the Trustee to instruct the Collateral Agent to enter into a supplemental indenture (the "Supplemental Indenture") to amend the Indenture to permit the Listing and/or the Reorganization Transactions; and (d) to the extent necessary under the Indenture, authorize and direct the Trustee and the Collateral Agent and authorize and direct the Trustee to instruct the Collateral Agent to enter into any amendments to or waive any provisions of the Indenture that would prohibit the Listing and/or the Reorganization Transactions.

The Solicitation will expire at 5:00 p.m., New York time, on March 1, 2012, unless extended or earlier terminated by the Issuer (the "Expiration Time"). The consideration for each US$1,000 principal amount of Notes for which a Consent is received prior to the Expiration Time and not validly revoked is US$5 (the "Consent Payment"). The payment of the Consent Payment on the Payment Date (which is expected to be March 6, 2012) is subject to the satisfaction or waiver of the Consent Payment Conditions as set forth in the Consent Solicitation Statement. Consents may be revoked prior to the earlier of (a) the Expiration Time and (b) the time at which the Supplemental Indenture has been executed (the "Effective Time") on the terms and conditions set out in the Consent Solicitation Statement. Adoption under the Indenture of the Proposed Amendments and Waivers requires the Consent of the Holders of at least a majority in aggregate principal amount of the outstanding Notes (the "Required Consents"). The Issuer anticipates that, promptly after receipt of the Required Consents at or prior to the Expiration Time, the Issuer will give notice to the Trustee that the Required Consents have been received and the Issuer, the Guarantors, the Trustee and the Collateral Agent will execute the Supplemental Indenture. Holders should note that they will not be given prior notice of such Effective Time. If the Proposed Amendments and Waivers become effective, they will be binding on all Holders, irrespective of whether such Holders delivered a Consent. The Parent, the Issuer and the Guarantors may decide not to undertake the Listing or the Corporate Reorganization Transactions even if the Required Consents are obtained and the Supplemental Indenture is executed. Holders (who are not themselves direct participants) who hold Euroclear/Clearstream Held Notes can only participate by requesting the direct participant to submit electronic instructions via Euroclear and Clearstream in accordance with their standard procedures. Holders (who are not themselves direct participants) who hold DTC Held Notes can only participate by requesting the direct participant to submit electronic instructions via DTC's ATOP system in accordance with DTC's standard procedures.

____________________________________

The Issuer has retained Citigroup Global Markets Limited as Solicitation Agent and Citibank, N.A., London Branch as Tabulation Agent with respect to the Solicitation.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This announcement includes forward-looking statements. All statements, other than statements of historical fact, included in this announcement regarding the Issuer's financial condition or regarding future events or prospects are forward-looking statements. The words "anticipate," "believe," "future," "intend," "may," "shall," "should," "will" or the negative or other variations of them as well as other statements regarding matters that are not historical fact, are or may constitute forward-looking statements. These forward-looking statements are based on the Issuer's and/or the Parent's management's current view with respect to future events and financial performance. These views reflect the best judgment of the Issuer's and/or the Parent's management but involve a number of risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from those predicted in the Issuer's forward-looking statements and from past results, performance or achievements. All forward-looking statements contained in this announcement are qualified in their entirety by this cautionary statement.

We do not intend to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. All subsequent written or oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements contained throughout this announcement. As a result of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements.

DISCLAIMER

This announcement is not a consent solicitation and must be read in conjunction with the Consent Solicitation Statement. This announcement and the Consent Solicitation Statement contain important information which should be read carefully before any decision is made with respect to the Proposed Amendments and Waivers. Those documents should be consulted for additional information regarding consent procedures and the conditions for the Solicitation. To receive copies of the Consent Solicitation Statement, or for questions relating to the Solicitation transaction, please contact the Solicitation Agent or Tabulation Agent at the contact information below. If any Holder is in any doubt as to the action it should take or is unsure of the impact of the implementation of the Proposed Amendments and Waivers, it is recommended to seek its own financial and legal advice, including as to any tax consequences, immediately from its stockbroker, bank manager, solicitor, accountant or other independent financial or legal adviser. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee or intermediary must contact such entity if it wishes to consent to the Proposed Amendments and Waivers. None of the Issuer, any other Guarantor, the Tabulation Agent, the Solicitation Agent, the Trustee or the Collateral Agent makes any recommendation whether Holders of Notes should consent to the proposed Amendments and Waivers.

Any deadlines set by any intermediary or clearing system will be earlier than the deadlines specified in the Consent Solicitation Statement.

Requests for information in relation to the Solicitation should be directed to:

 

Solicitation Agent:

 

Citigroup Global Markets Limited

Citigroup Centre

Canada Square

Canary Wharf

London E14 5LB

United Kingdom

Attention: Liability Management Group

London: +44 (0) 20 7986 8969

Toll Free: (800) 558 3745

Collect: (212) 723 6106

E-mail: liabilitymanagement.europe@citi.com

 

Tabulation Agent:

 

Citibank, N.A., London Branch

14th Floor

Citigroup Centre

Canada Square

Canary Wharf

London E14 5LB

United Kingdom

Attention: Exchange Team

The Tabulation Agent may be contacted at:

+44 (0) 20 7508 3867

Facsimile Transmission Number: +44 (0)20 3320 2405 (for eligible institutions only)

E-mail: exchange.gats@citi.com

Attention: Exchange Team

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEAFEFFESEFE
Date   Source Headline
30th May 20247:00 amRNSFinancial Results for Q1 ended 31 March 2024
10th May 20249:00 amRNSPublication of ARA and Notice of 2024 AGM
3rd May 20242:44 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSOperational Update for Q1 2024
29th Apr 202411:00 amRNS2023 Report on Payments to Governments
19th Apr 20246:22 pmRNSFull Year Results
19th Apr 20247:30 amRNSHolding(s) in Company
17th Apr 20245:41 pmRNSHolding(s) in Company
2nd Apr 202411:08 amRNSApproval of Investment in Stepnoy Leopard Field
2nd Apr 20247:00 amRNSUpdate on operations at the Stepnoy Leopard Fields
2nd Apr 20247:00 amRNSUpdate on operations at the Chinarevskoye Field
21st Mar 202410:00 amRNSNotice of Revised 2023 Full Year Results Date
21st Feb 20247:00 amRNSCompletion of delisting from the AIX
29th Jan 20247:00 amRNSOperational Update for FY 2023
28th Dec 202310:40 amRNSHolding(s) in Company
22nd Dec 202311:22 amRNSProposed delisting of ordinary shares from the AIX
21st Dec 202310:28 amRNSStart of Ural OG tie-back and receipt of first gas
19th Dec 202310:55 amRNSAdjourned Meeting Results
19th Dec 20237:00 amRNSRe-entry drilling at the Chinarevskoye Field
12th Dec 202310:12 amRNSANNOUNCEMENT OF ADJOURNMENT
30th Nov 20235:12 pmRNSHolding(s) in Company
21st Nov 20238:00 amRNSSOLICITATION OF CONSENTS IN RESPECT OF NOTES
21st Nov 20237:00 amRNSFinancial Results for 3Q and 9M ended 30 Sep 2023
27th Oct 20237:00 amRNSOperational Update for 3Q and 9M
5th Oct 20237:00 amRNSHolding(s) in Company
29th Sep 20237:00 amRNSAppraisal Campaign at the Stepnoy Leopard Fields
26th Sep 20231:13 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSHolding(s) in Company
18th Sep 202311:45 amRNSHolding(s) in Company
4th Sep 20237:00 amRNSRe-Start of Gas Treatment Unit 3
22nd Aug 20237:00 amRNSFinancial Results for 2Q and 6M ended 30 June 2023
21st Aug 20237:00 amRNSDrilling Update at the Chinarevskoye Field
2nd Aug 202310:30 amRNSAppointment of Corporate Broker
1st Aug 20232:10 pmRNSAppraisal Programme at the Stepnoy Leopard Fields
28th Jul 20237:00 amRNSOperational Update for 2Q and 6M
24th Jul 20239:00 amRNSGas lift system expansion
17th Jul 202312:27 pmRNSAcquisition of the Stepnoy Leopard Fields
30th Jun 202312:34 pmRNSResult of AGM
30th Jun 20237:00 amRNS1st Quarter Results
29th Jun 20233:14 pmRNSNotice of Revised Q1 2023 Financial Results Date
27th Jun 20239:37 amRNS2022 Report on Payments to Governments
23rd Jun 20237:00 amRNSCFO Appointment
6th Jun 20234:00 pmRNSNotice of AGM
2nd Jun 20235:58 pmRNSApplication for restoration of listing of Shares
2nd Jun 20238:03 amRNSFull Year Results for the Year Ending 31 Dec 2022
31st May 20238:55 amRNSNotice of Revised 2022 Full Year Results Date
5th May 20232:20 pmRNSSuspension of trading in shares on the AIX
2nd May 20238:54 amRNSSuspension of listing of Shares
28th Apr 20237:00 amRNSOperational Update for Q1 ending 31 March 2023
26th Apr 20234:23 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.